Short answer
Crinetics Pharmaceuticals, Inc. (CRNX) filed an 8-K current report with the SEC on March 3, 2026 reporting Item 4.01 (Changes in Registrant's Certifying Accountant). BDO dismissed as auditor effective Feb 27, 2026; replaced by PricewaterhouseCoopers LLP for fiscal year 2026.
- This filing includes Item 4.01, an item that often signal trouble.
Crinetics Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 4.01 · Changes in Registrant's Certifying Accountant
- BDO dismissed as auditor effective Feb 27, 2026; replaced by PricewaterhouseCoopers LLP for fiscal year 2026
- Clean transition: no disagreements, no reportable events, no adverse opinions in BDO's reports for FY2024 and FY2025
- PwC had zero prior consultation with CRNX: standard arms-length appointment, no pre-arrangement concerns
- Upgrade signal: moving from BDO to Big Four firm PwC often reflects company maturation or preparation for increased institutional scrutiny
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Crinetics Pharmaceuticals, Inc. 8-K filings
Get the next CRNX 8-K as it lands
Follow CRNX for push alerts, or ask the research agent what this filing means.